Literature DB >> 23855979

Substantial effects of apolipoprotein E ε4 on memory decline in very old age: longitudinal findings from a population-based sample.

Marcus Praetorius1, Valgeir Thorvaldsson, Linda B Hassing, Boo Johansson.   

Abstract

We examined associations between the apolipoprotein E (APOE) ε4 allele and levels of performance and rates of change in cognition in late life taking incident dementia into account. The sample consisted of 482 nondemented individuals, aged 80 years and older at baseline, drawn from the OCTO twin study. A battery of 10 cognitive tests was administered at 5 occasions with measurements intervals of 2 years. We fitted hierarchical linear models with time specified as time to death and controlled for baseline age, sex, education, stroke, cardiovascular disease, hypertension, diabetes, and incident dementia. The ε4 allele was significantly associated with lower levels of performance or steeper rate of decline in all 7 memory tests. Largest effect sizes were found in tests of delayed recall and recognition memory. The effects of the APOE ε4 allele were, however, reduced to a nonsignificant level in all tests except 1 after accounting for incident dementia. The findings support the notion that the APOE ε4 allele is associated with substantial memory decline in very old age, but as expected, the effect is largely related to incident dementia.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOE; Cognition; Cognitive change; Cognitive performance; Oldest old

Mesh:

Substances:

Year:  2013        PMID: 23855979     DOI: 10.1016/j.neurobiolaging.2013.06.002

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  7 in total

1.  Apolipoprotein E ε4 allele effects on longitudinal cognitive trajectories are sex and age dependent.

Authors:  Owen A Williams; Yang An; Nicole M Armstrong; Andrea T Shafer; Jessica Helphrey; Melissa Kitner-Triolo; Luigi Ferrucci; Susan M Resnick
Journal:  Alzheimers Dement       Date:  2019-09-24       Impact factor: 21.566

2.  Effects of APOE on cognitive aging in community-dwelling older adults.

Authors:  Emilie T Reas; Gail A Laughlin; Jaclyn Bergstrom; Donna Kritz-Silverstein; Elizabeth Barrett-Connor; Linda K McEvoy
Journal:  Neuropsychology       Date:  2019-02-07       Impact factor: 3.295

3.  APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.

Authors:  Sarah T Pendlebury; Debbie Poole; Annette Burgess; Julia Duerden; Peter M Rothwell
Journal:  Stroke       Date:  2020-02-18       Impact factor: 7.914

4.  The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes.

Authors:  Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Mary Sano; Rachel Preiss; Keren Koifman; Hadas Hoffman; Jeremy M Silverman; Michal Schnaider Beeri
Journal:  Eur Neuropsychopharmacol       Date:  2014-05-14       Impact factor: 4.600

5.  Changes in Frailty Predict Changes in Cognition in Older Men: The Honolulu-Asia Aging Study.

Authors:  Joshua J Armstrong; Judith Godin; Lenore J Launer; Lon R White; Arnold Mitnitski; Kenneth Rockwood; Melissa K Andrew
Journal:  J Alzheimers Dis       Date:  2016-06-15       Impact factor: 4.472

6.  Cognitive dispersion and ApoEe4 genotype predict dementia diagnosis in 8-year follow-up of the oldest-old.

Authors:  Tam Watermeyer; Jantje Goerdten; Boo Johansson; Graciela Muniz-Terrera
Journal:  Age Ageing       Date:  2021-05-05       Impact factor: 10.668

7.  Does incipient dementia explain normal cognitive decline determinants? Lothian birth cohort 1921.

Authors:  Ruth A Sibbett; Tom C Russ; Alison Pattie; John M Starr; Ian J Deary
Journal:  Psychol Aging       Date:  2018-05-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.